Getting the right results is in our DNA
Our in-depth Biological Sequence Search is designed to unearth even the most hard-to-find sequences hidden deep within a wide array of patent and non-patent literature, making it ideal for Fortune 500s and world-renowned research labs developing antibodies, primers and therapies including peptides/ nucleic acids.
When one of the World’s Top Antibody producing Company wanted to have an expert opinion on the Freedom to Operate for an antibody developed in-house and its subsequent potential, they chose Sagacious.
When a global leader in Healthcare wanted to market one of their high potential therapy involving a recent developed marker an antibody, they chose Sagacious.
When an oncology-based company, wanted to enquire about the recent therapies developed for the cancer treatment and check if their developed therapy aligns to any prevalent one, they chose Sagacious.
When a Swiss Company wanted to test the novelty of one of its developed oligonucleotide and wanted to subsequently explore the related applications in the market of interest, they chose Sagacious,